Feedback related to Pharmaceutical Sector General Remarks on the Strategy We support the proposed overall SAG strategy with minor amendments There is a need to review and revise the current ID: 739127
Download Presentation The PPT/PDF document "Juanita Folmsbee , Country Project Dire..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Juanita
Folmsbee,Country Project Director, SIAPS program
Feedback related to Pharmaceutical SectorSlide2
General Remarks on the Strategy
We support the proposed overall SAG strategy with
minor amendments
There is a need to review and revise the current
Concept for Development of the Pharmaceutical Sector (2011-2020)
and link
to
health
sector
reform.
Statements on price
setting mechanisms
(line 812) in
this overarching policy document is premature
until
overarching pharmaceutical policy objectives have been established
It reduces
future policy
flexibilitySlide3
General Remarks on the Strategy
(2)
There is a focus on tasks and mechanisms in the area of pharmaceutical management
W
e would like to see a clear focus of what the final expected outcome is rather than leaving it at the detailed implementation plan phase (page 24, line 900)Slide4
Suggestions to the Strategy
(1)
The term “National EML” is mentioned the first time
in line 810 without emphasizing the importance of updating the current EML to address
the needs of the health system at various
levels.
SAG needs to recommend legislation
to mandate use of the
EML/harmonized list of medicines
as the basis for public procurement and/or
reimbursement.
This
harmonized list of medicines should clearly designate/authorize the use of the medicines at various levels of the health system
.
This is
critical
to
meet health sector
reform goalsSlide5
Suggestions to the Strategy
(2)
Pharmaceutical regulation is fragmented across
the SAUMP and the SEC – leading to lack of clarity for manufacturers, importers, etc.
The SAG should make a strong recommendation to
S
treamline
and
simplify
the two different entities
to better
rationalize their roles and responsibilities
Then the stated goal of pharmaceutical reform in line 780 can be achievedSlide6
Suggestions to the Strategy
(3)
Rational
use of resources is mentioned several times in relation to services, infrastructure, funding, etc.
There is however, no statement on rational use of medicines*
RUM is critical to improving efficiency
and essential to the long term sustainability of the system, given resource limitations
* Prescribing, dispensing, use,
pharmacovigilance
, quality,
etc